Omega Healthcare Investors Key Executives
This section highlights Omega Healthcare Investors's key executives, including their titles and compensation details.
Find Contacts at Omega Healthcare Investors
(Showing 0 of )
Omega Healthcare Investors Earnings
This section highlights Omega Healthcare Investors's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-06 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-10-31 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-08-02 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-05-03 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-02-08 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-11-03 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-08-03 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-05-03 | N/A | N/A |
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
$38.00
Stock Price
$10.71B
Market Cap
60
Employees
Hunt Valley, MD
Location
Financial Statements
Access annual & quarterly financial statements for Omega Healthcare Investors, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $1.05B | $949.74M | $878.24M | $1.06B | $892.38M |
| Cost of Revenue | $14.56M | $59.58M | $16.97M | $13.72M | $13.76M |
| Gross Profit | $1.04B | $890.16M | $861.27M | $1.05B | $878.62M |
| Gross Profit Ratio | 98.62% | 93.70% | 98.07% | 98.70% | 98.46% |
| Research and Development Expenses | $- | $- | $0 | $0 | $0 |
| General and Administrative Expenses | $88.00M | $81.50M | $67.93M | $63.17M | $58.44M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $88.00M | $81.50M | $67.93M | $63.17M | $58.44M |
| Other Expenses | $- | $- | $401.07M | $419.75M | $367.92M |
| Operating Expenses | $49.27M | $81.50M | $469.00M | $482.92M | $426.36M |
| Cost and Expenses | $102.56M | $141.09M | $485.97M | $496.63M | $440.13M |
| Interest Income | $- | $- | $123.92M | $234.60M | $223.39M |
| Interest Expense | $221.72M | $235.53M | $233.24M | $234.60M | $224.35M |
| Depreciation and Amortization | $304.65M | $319.68M | $485.97M | $496.63M | $648.89M |
| EBITDA | $947.11M | $810.84M | $722.69M | $906.89M | $782.18M |
| EBITDA Ratio | 90.08% | 85.38% | 82.29% | 85.33% | 87.65% |
| Operating Income | $1.00B | $761.27M | $390.28M | $564.88M | $452.25M |
| Operating Income Ratio | 95.31% | 80.16% | 44.44% | 53.15% | 50.68% |
| Total Other Income Expenses Net | $-581.37M | $-505.63M | $-318.75M | $-525.18M | $-585.36M |
| Income Before Tax | $420.75M | $255.63M | $436.14M | $416.08M | $162.33M |
| Income Before Tax Ratio | 40.02% | 26.92% | 49.66% | 39.15% | 18.19% |
| Income Tax Expense | $10.86M | $6.25M | $4.56M | $3.84M | $4.92M |
| Net Income | $406.33M | $242.18M | $426.93M | $416.74M | $159.33M |
| Net Income Ratio | 38.65% | 25.50% | 48.61% | 39.21% | 17.85% |
| EPS | $1.53 | $1.04 | $1.81 | $1.76 | $0.70 |
| EPS Diluted | $1.46 | $1.00 | $1.75 | $1.71 | $0.68 |
| Weighted Average Shares Outstanding | 258.12M | 240.49M | 236.26M | 236.93M | 227.74M |
| Weighted Average Shares Outstanding Diluted | 270.45M | 250.45M | 244.29M | 244.34M | 235.10M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $279.32M | $276.03M | $255.34M | $245.90M | $239.32M | $242.03M | $250.19M | $218.20M | $144.85M | $239.43M | $244.65M | $249.31M | $249.95M | $281.67M | $257.42M | $273.77M | $263.79M | $119.18M | $256.39M | $253.02M |
| Cost of Revenue | $- | $12.19M | $77.98M | $78.36M | $3.21M | $32.28M | $4.42M | $4.37M | $4.37M | $4.54M | $4.08M | $3.97M | $3.62M | $3.64M | $3.37M | $3.09M | $3.23M | $2.49M | $4.02M | $4.03M |
| Gross Profit | $279.32M | $263.84M | $177.36M | $167.54M | $236.11M | $209.75M | $245.76M | $213.84M | $140.48M | $234.89M | $240.56M | $245.34M | $246.32M | $278.03M | $254.05M | $270.68M | $260.56M | $116.69M | $252.38M | $249.00M |
| Gross Profit Ratio | 100.00% | 95.60% | 69.50% | 68.10% | 98.70% | 86.70% | 98.20% | 98.00% | 97.00% | 98.10% | 98.30% | 98.40% | 98.60% | 98.70% | 98.70% | 98.90% | 98.78% | 97.91% | 98.43% | 98.41% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $12.86M | $21.76M | $22.15M | $21.53M | $18.53M | $11.03M | $21.66M | $20.16M | $15.63M | $17.88M | $18.41M | $16.02M | $17.54M | $15.01M | $14.83M | $15.79M | $14.82M | $14.45M | $13.61M | $15.56M |
| Selling and Marketing Expenses | $- | $- | $- | $9.23M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $12.86M | $21.76M | $22.15M | $21.53M | $18.53M | $11.03M | $21.66M | $20.16M | $15.63M | $17.88M | $18.41M | $16.02M | $17.54M | $15.01M | $14.83M | $15.79M | $14.82M | $14.45M | $13.61M | $15.56M |
| Other Expenses | $- | $- | $3.36M | $-30.00M | $11.15M | $5.40M | $1.03M | $77.14M | $148.03M | $86.81M | $81.64M | $84.58M | $-632.00K | $-749.00K | $518.00K | $231.00K | $87.04M | $113.15M | $83.60M | $84.13M |
| Operating Expenses | $12.86M | $21.76M | $82.21M | $30.00M | $127.12M | $11.03M | $116.64M | $97.29M | $163.66M | $104.69M | $100.05M | $100.59M | $152.52M | $126.61M | $104.17M | $99.62M | $101.87M | $127.60M | $97.21M | $99.69M |
| Cost and Expenses | $12.86M | $33.95M | $85.96M | $108.36M | $130.33M | $43.31M | $121.07M | $101.66M | $168.03M | $109.23M | $104.14M | $104.56M | $156.14M | $130.25M | $107.54M | $102.71M | $105.10M | $130.09M | $101.22M | $103.72M |
| Interest Income | $- | $- | $38.04M | $35.84M | $31.61M | $30.62M | $29.23M | $28.42M | $123.92M | $58.24M | $- | $- | $- | $- | $- | $- | $593.00K | $- | $141.00K | $- |
| Interest Expense | $55.24M | $54.69M | $53.97M | $57.82M | $59.43M | $55.29M | $58.78M | $58.55M | $58.49M | $58.24M | $58.37M | $58.15M | $58.23M | $58.98M | $58.88M | $58.96M | $58.95M | $55.24M | $55.25M | $55.94M |
| Depreciation and Amortization | $78.61M | $77.25M | $74.23M | $74.56M | $75.67M | $80.80M | $82.02M | $81.19M | $83.74M | $82.71M | $83.21M | $82.75M | $85.27M | $86.10M | $85.80M | $84.85M | $82.62M | $81.07M | $83.59M | $82.64M |
| EBITDA | $251.05M | $243.29M | $243.62M | $212.10M | $188.34M | $236.59M | $212.17M | $200.46M | $63.59M | $212.73M | $219.31M | $227.07M | $179.86M | $287.33M | $231.29M | $255.91M | $241.31M | $18.36M | $185.97M | $179.21M |
| EBITDA Ratio | 89.88% | 88.14% | 95.41% | 86.25% | 81.82% | 96.31% | 84.80% | 91.87% | 43.90% | 88.85% | 89.64% | 91.08% | 71.39% | 84.06% | 91.76% | 93.48% | 91.48% | 58.87% | 93.18% | 91.67% |
| Operating Income | $266.46M | $242.08M | $169.38M | $137.54M | $222.39M | $198.72M | $130.15M | $119.26M | $-20.14M | $130.02M | $136.11M | $144.32M | $92.48M | $151.42M | $149.88M | $171.06M | $158.69M | $-39.48M | $156.53M | $147.73M |
| Operating Income Ratio | 95.40% | 87.70% | 66.34% | 55.93% | 92.92% | 82.10% | 52.02% | 54.66% | -13.91% | 54.30% | 55.63% | 57.89% | 37.00% | 53.76% | 58.23% | 62.48% | 60.16% | -33.12% | 61.05% | 58.39% |
| Total Other Income Expenses Net | $-147.81M | $-130.73M | $-99.75M | $-140.85M | $-251.31M | $-118.11M | $-68.11M | $-82.90M | $-12.56M | $-29.13M | $-50.34M | $-31.06M | $-60.10M | $-95.26M | $-64.00M | $-18.18M | $-94.81M | $-55.22M | $-55.11M | $-56.01M |
| Income Before Tax | $118.65M | $111.35M | $118.92M | $71.83M | $61.82M | $97.01M | $62.08M | $34.72M | $47.99M | $102.14M | $91.25M | $194.76M | $33.71M | $142.26M | $86.61M | $153.49M | $63.88M | $-94.70M | $101.42M | $91.72M |
| Income Before Tax Ratio | 42.48% | 40.34% | 46.57% | 29.21% | 25.83% | 40.08% | 24.81% | 15.91% | 33.13% | 42.66% | 37.30% | 78.12% | 13.49% | 50.51% | 33.65% | 56.07% | 24.22% | -79.46% | 39.55% | 36.25% |
| Income Tax Expense | $-2.98M | $3.32M | $1.98M | $2.58M | $4.16M | $-1.76M | $1.63M | $-1.29M | $1.03M | $1.19M | $1.12M | $1.23M | $967.00K | $976.00K | $939.00K | $958.00K | $2.30M | $763.00K | $858.00K | $1.00M |
| Net Income | $113.34M | $111.76M | $113.86M | $67.36M | $55.00M | $91.38M | $59.86M | $35.94M | $45.58M | $102.27M | $89.47M | $189.61M | $33.29M | $138.95M | $84.52M | $159.98M | $61.40M | $-91.29M | $99.31M | $89.92M |
| Net Income Ratio | 40.58% | 40.49% | 44.59% | 27.39% | 22.98% | 37.76% | 23.92% | 16.47% | 31.47% | 42.72% | 36.57% | 76.05% | 13.32% | 49.33% | 32.83% | 58.44% | 23.28% | -76.60% | 38.73% | 35.54% |
| EPS | $0.40 | $0.44 | $0.46 | $0.27 | $0.22 | $0.37 | $0.25 | $0.15 | $0.19 | $0.44 | $0.38 | $0.79 | $0.14 | $0.58 | $0.36 | $0.69 | $0.27 | $-0.40 | $0.44 | $0.40 |
| EPS Diluted | $0.38 | $0.41 | $0.45 | $0.27 | $0.21 | $0.37 | $0.25 | $0.15 | $0.19 | $0.42 | $0.37 | $0.77 | $0.14 | $0.58 | $0.36 | $0.69 | $0.27 | $-0.39 | $0.43 | $0.39 |
| Weighted Average Shares Outstanding | 274.32M | 252.72M | 249.37M | 246.07M | 245.75M | 245.03M | 236.23M | 234.95M | 234.86M | 234.79M | 236.23M | 239.53M | 239.65M | 239.28M | 236.23M | 232.57M | 228.78M | 227.51M | 227.41M | 227.26M |
| Weighted Average Shares Outstanding Diluted | 287.45M | 275.56M | 261.53M | 257.26M | 256.56M | 255.96M | 246.10M | 243.19M | 242.99M | 243.28M | 243.33M | 247.56M | 246.92M | 246.62M | 243.91M | 239.91M | 236.81M | 233.68M | 234.52M | 234.51M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $518.34M | $442.81M | $297.10M | $20.53M | $163.53M |
| Short Term Investments | $- | $- | $8.50M | $- | $- |
| Cash and Short Term Investments | $518.34M | $442.81M | $297.10M | $20.53M | $163.53M |
| Net Receivables | $1.43B | $232.13M | $1.46B | $1.58B | $1.14B |
| Inventory | $- | $- | $499.67M | $1 | $498.11M |
| Other Current Assets | $86.59M | $107.66M | $13.00M | $206.90M | $85.47M |
| Total Current Assets | $2.64B | $782.60M | $1.77B | $1.39B | $1.39B |
| Property Plant Equipment Net | $- | $30.18M | $17.85M | $-8.20M | $-10.77M |
| Goodwill | $643.66M | $643.90M | $643.15M | $651.42M | $651.74M |
| Intangible Assets | $- | $- | $1.45M | $1.62M | $1.94M |
| Goodwill and Intangible Assets | $643.66M | $643.90M | $643.15M | $651.42M | $651.74M |
| Long Term Investments | $88.71M | $188.41M | $178.92M | $664.57M | $668.08M |
| Tax Assets | $- | $- | $-17.85M | $8.20M | $10.77M |
| Other Non-Current Assets | $-88.71M | $5.99B | $6.81B | $6.93B | $6.79B |
| Total Non-Current Assets | $643.66M | $6.86B | $7.63B | $8.24B | $8.11B |
| Other Assets | $6.62B | $1.48B | $- | $- | $- |
| Total Assets | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B |
| Account Payables | $- | $- | $- | $- | $- |
| Short Term Debt | $- | $426.63M | $352.16M | $- | $101.16M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- |
| Other Current Liabilities | $328.19M | $236.51M | $274.08M | $268.52M | $224.96M |
| Total Current Liabilities | $328.19M | $663.13M | $334.29M | $268.52M | $381.98M |
| Long Term Debt | $4.84B | $4.65B | $4.93B | $5.28B | $5.11B |
| Deferred Revenue Non-Current | $- | $- | $5.60B | $-248.48M | $-242.31M |
| Deferred Tax Liabilities Non-Current | $- | $- | $40.97M | $8.20M | $10.77M |
| Other Non-Current Liabilities | $- | $44.75M | $340.65M | $-28.23M | $17.35M |
| Total Non-Current Liabilities | $4.84B | $4.69B | $5.27B | $5.26B | $5.08B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $5.17B | $5.36B | $5.60B | $5.53B | $5.46B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $27.91M | $24.53M | $23.43M | $23.91M | $23.12M |
| Retained Earnings | $- | $-3.15B | $-2.75B | $-2.54B | $-2.32B |
| Accumulated Other Comprehensive Income Loss | $22.73M | $29.34M | $20.32M | $-2.20M | $-12.77M |
| Other Total Stockholders Equity | $4.49B | $6.67B | $6.31B | $6.43B | $6.15B |
| Total Stockholders Equity | $4.54B | $3.57B | $3.61B | $3.91B | $3.84B |
| Total Equity | $4.73B | $3.76B | $3.80B | $4.11B | $4.04B |
| Total Liabilities and Stockholders Equity | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B |
| Minority Interest | $194.17M | $187.71M | $193.91M | $201.39M | $194.73M |
| Total Liabilities and Total Equity | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B |
| Total Investments | $88.71M | $188.41M | $7.78B | $664.57M | $668.08M |
| Total Debt | $4.84B | $5.07B | $5.29B | $5.25B | $5.17B |
| Net Debt | $4.32B | $4.62B | $4.99B | $5.23B | $5.01B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $518.34M | $342.44M | $39.13M | $363.03M | $442.81M | $554.71M | $350.69M | $245.18M | $297.10M | $134.85M | $164.95M | $491.25M | $20.53M | $102.66M | $100.82M | $51.38M | $163.53M | $35.95M | $37.02M | $347.96M |
| Short Term Investments | $- | $- | $- | $- | $7.19B | $7.39B | $- | $- | $8.50M | $10.56M | $10.88M | $- | $10.87M | $8.00B | $7.99B | $8.10B | $7.68B | $7.75B | $7.87B | $7.89B |
| Cash and Short Term Investments | $518.34M | $342.44M | $39.13M | $363.03M | $442.81M | $554.71M | $350.69M | $245.18M | $297.10M | $134.85M | $164.95M | $491.25M | $20.53M | $102.66M | $100.82M | $51.38M | $163.53M | $35.95M | $37.02M | $347.96M |
| Net Receivables | $1.43B | $1.92B | $1.86B | $1.76B | $1.72B | $1.58B | $1.54B | $1.46B | $1.46B | $956.93M | $1.00B | $1.11B | $1.58B | $1.14B | $1.11B | $1.15B | $1.14B | $1.14B | $1.33B | $1.19B |
| Inventory | $- | $- | $- | $1 | $766.90M | $837.70M | $573.22M | $1 | $499.67M | $10.56M | $10.88M | $- | $10.87M | $- | $- | $- | $- | $1 | $1 | $- |
| Other Current Assets | $86.59M | $93.84M | $80.56M | $82.80M | $95.63M | $70.74M | $7.22M | $29.10M | $13.00M | $194.05M | $65.14M | $96.30M | $206.90M | $24.87M | $39.07M | $12.44M | $85.47M | $40.09M | $75.06M | $28.18M |
| Total Current Assets | $2.64B | $2.36B | $1.98B | $2.20B | $2.26B | $2.21B | $1.90B | $1.73B | $1.77B | $1.29B | $1.23B | $1.70B | $1.39B | $1.27B | $1.25B | $1.21B | $1.39B | $1.22B | $1.44B | $1.57B |
| Property Plant Equipment Net | $- | $- | $5.88B | $5.83B | $30.18M | $6.19B | $6.49B | $6.44B | $17.85M | $6.46B | $6.68B | $6.80B | $6.78B | $7.09B | $7.08B | $7.18B | $6.72B | $6.80B | $6.90B | $7.09B |
| Goodwill | $643.66M | $644.59M | $643.79M | $643.78M | $643.90M | $643.34M | $643.86M | $643.50M | $643.15M | $648.95M | $649.97M | $651.02M | $651.42M | $651.35M | $651.70M | $651.68M | $651.74M | $644.08M | $643.49M | $643.54M |
| Intangible Assets | $- | $- | $653.00K | $667.00K | $682.00K | $696.00K | $5.59M | $1.41M | $1.45M | $1.48M | $1.52M | $1.56M | $1.62M | $1.69M | $1.77M | $674.50M | $1.94M | $2.30M | $4.57M | $27.29M |
| Goodwill and Intangible Assets | $643.66M | $644.59M | $643.79M | $643.78M | $643.90M | $643.34M | $643.86M | $643.50M | $643.15M | $648.95M | $649.97M | $651.02M | $651.42M | $651.35M | $651.70M | $651.68M | $651.74M | $644.08M | $643.49M | $643.54M |
| Long Term Investments | $88.71M | $92.60M | $185.27M | $190.52M | $188.41M | $187.54M | $191.67M | $181.34M | $178.92M | $784.75M | $744.58M | $699.18M | $664.57M | $627.77M | $656.58M | $649.37M | $668.08M | $660.72M | $630.20M | $619.13M |
| Tax Assets | $- | $- | $20.55M | $8.91M | $9.55M | $9.64M | $10.54M | $10.78M | $-17.85M | $-6.46B | $-6.68B | $-6.80B | $8.20M | $8.80M | $9.64M | $10.25M | $-6.72B | $9.62M | $9.68M | $10.19M |
| Other Non-Current Assets | $-88.71M | $-92.60M | $142.37M | $130.78M | $5.98B | $182.26M | $167.47M | $283.01M | $6.81B | $6.76B | $6.89B | $6.96B | $138.80M | $140.75M | $113.23M | $117.65M | $6.79B | $71.26M | $68.67M | $104.57M |
| Total Non-Current Assets | $643.66M | $644.59M | $6.87B | $6.81B | $6.86B | $7.22B | $7.50B | $7.56B | $7.63B | $8.19B | $8.29B | $8.31B | $8.24B | $8.51B | $8.51B | $8.61B | $8.11B | $8.18B | $8.25B | $8.47B |
| Other Assets | $6.62B | $5.94B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $9.90B | $8.94B | $8.85B | $9.01B | $9.12B | $9.43B | $9.40B | $9.29B | $9.41B | $9.48B | $9.52B | $10.01B | $9.64B | $9.78B | $9.76B | $9.82B | $9.50B | $9.40B | $9.69B | $10.04B |
| Account Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Short Term Debt | $- | $- | $- | $420.14M | $551.14M | $- | $350.00M | $352.16M | $352.16M | $- | $- | $2.27M | $- | $- | $- | $135.00M | $101.16M | $- | $- | $- |
| Tax Payables | $- | $- | $7.63M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $8.20M | $- | $- | $- | $10.77M | $- | $- | $- |
| Other Current Liabilities | $328.19M | $313.37M | $667.88M | $270.61M | $111.99M | $262.75M | $289.57M | $300.99M | $274.08M | $271.48M | $306.39M | $230.38M | $268.52M | $231.26M | $266.82M | $224.54M | $-90.39M | $253.66M | $501.39M | $230.62M |
| Total Current Liabilities | $328.19M | $313.37M | $357.58M | $303.32M | $308.19M | $296.24M | $324.90M | $336.44M | $334.29M | $313.31M | $306.39M | $611.28M | $268.52M | $260.63M | $266.82M | $391.34M | $381.98M | $448.26M | $501.39M | $805.50M |
| Long Term Debt | $4.84B | $4.86B | $4.67B | $4.61B | $4.56B | $5.29B | $4.94B | $4.94B | $4.93B | $5.27B | $5.31B | $5.63B | $5.28B | $5.27B | $5.27B | $5.27B | $5.09B | $5.17B | $5.23B | $5.52B |
| Deferred Revenue Non-Current | $- | $- | $10.52M | $148.11M | $-244.56M | $-263.87M | $-289.57M | $-300.99M | $- | $- | $- | $- | $-5.52B | $-231.26M | $-236.26M | $-224.54M | $-5.45B | $-33.55M | $-59.49M | $-68.32M |
| Deferred Tax Liabilities Non-Current | $- | $- | $1.32M | $1.43M | $1.51M | $1.12M | $1.42M | $1.82M | $- | $- | $- | $- | $8.20M | $8.80M | $9.64M | $10.25M | $10.77M | $9.62M | $9.68M | $10.19M |
| Other Non-Current Liabilities | $- | $- | $-398.68M | $12.49M | $132.57M | $13.96M | $15.00M | $15.67M | $340.65M | $- | $-38.00M | $26.01M | $-28.23M | $29.37M | $- | $31.80M | $353.87M | $23.93M | $-216.43M | $58.13M |
| Total Non-Current Liabilities | $4.84B | $4.86B | $4.59B | $5.01B | $5.05B | $5.27B | $5.27B | $5.27B | $5.27B | $5.27B | $5.27B | $5.27B | $5.26B | $5.28B | $5.28B | $5.28B | $5.08B | $5.01B | $5.02B | $5.01B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $5.17B | $5.17B | $4.95B | $5.31B | $5.36B | $5.57B | $5.59B | $5.60B | $5.60B | $5.58B | $5.58B | $5.88B | $5.53B | $5.54B | $5.55B | $5.67B | $5.46B | $5.46B | $5.52B | $5.82B |
| Preferred Stock | $- | $- | $6.99B | $3.22B | $3.15B | $3.04B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $101.00K | $235.00K | $- |
| Common Stock | $27.91M | $26.82M | $25.40M | $24.64M | $24.53M | $24.50M | $24.10M | $23.43M | $23.43M | $23.42M | $23.41M | $23.82M | $23.91M | $23.89M | $23.76M | $23.34M | $23.12M | $22.70M | $22.69M | $22.69M |
| Retained Earnings | $- | $-3.36B | $-3.30B | $-3.25B | $-3.15B | $-3.04B | $-2.97B | $-2.87B | $-2.75B | $-2.64B | $-2.58B | $-2.51B | $-2.54B | $-2.42B | $-2.39B | $-2.32B | $-2.32B | $-2.23B | $-1.99B | $-1.93B |
| Accumulated Other Comprehensive Income Loss | $22.73M | $62.74M | $-54.92M | $-55.78M | $29.34M | $28.14M | $41.35M | $21.53M | $20.32M | $6.24M | $3.50M | $6.32M | $-2.20M | $1.48M | $4.52M | $23.23M | $-12.77M | $-49.10M | $-66.23M | $-65.79M |
| Other Total Stockholders Equity | $4.49B | $7.48B | $6.95B | $6.79B | $6.67B | $6.66B | $6.53B | $6.32B | $6.31B | $6.31B | $6.30B | $6.40B | $6.43B | $6.43B | $6.38B | $6.23B | $6.15B | $6.00B | $6.00B | $6.00B |
| Total Stockholders Equity | $4.54B | $4.21B | $3.71B | $3.51B | $3.57B | $3.67B | $3.62B | $3.50B | $3.61B | $3.70B | $3.74B | $3.92B | $3.91B | $4.04B | $4.01B | $3.95B | $3.84B | $3.74B | $3.97B | $4.02B |
| Total Equity | $4.73B | $4.40B | $3.90B | $3.70B | $3.76B | $3.86B | $3.81B | $3.69B | $3.80B | $3.90B | $3.94B | $4.13B | $4.11B | $4.24B | $4.21B | $4.15B | $4.04B | $3.94B | $4.17B | $4.22B |
| Total Liabilities and Stockholders Equity | $9.90B | $9.57B | $8.85B | $9.01B | $9.12B | $9.43B | $9.40B | $9.29B | $9.41B | $9.48B | $9.52B | $10.01B | $9.64B | $9.78B | $9.76B | $9.82B | $9.50B | $9.40B | $9.69B | $10.04B |
| Minority Interest | $194.17M | $192.36M | $189.69M | $186.71M | $187.71M | $188.34M | $188.47M | $188.55M | $193.91M | $197.41M | $199.62M | $212.01M | $201.39M | $201.48M | $197.97M | $194.94M | $194.73M | $193.85M | $197.16M | $197.07M |
| Total Liabilities and Total Equity | $9.90B | $9.57B | $8.85B | $9.01B | $9.12B | $9.43B | $9.40B | $9.29B | $9.41B | $9.48B | $9.52B | $10.01B | $9.64B | $9.78B | $9.76B | $9.82B | $9.50B | $9.40B | $9.69B | $10.04B |
| Total Investments | $88.71M | $92.60M | $185.27M | $190.52M | $7.38B | $7.58B | $191.67M | $181.34M | $7.78B | $795.31M | $755.46M | $699.18M | $675.44M | $8.63B | $8.65B | $8.75B | $8.35B | $8.41B | $8.50B | $8.51B |
| Total Debt | $4.84B | $4.86B | $4.67B | $5.04B | $5.07B | $5.29B | $5.29B | $5.29B | $5.29B | $5.28B | $5.31B | $5.63B | $5.25B | $5.27B | $5.27B | $5.41B | $5.17B | $5.17B | $5.23B | $5.52B |
| Net Debt | $4.32B | $4.52B | $4.63B | $4.68B | $4.62B | $4.74B | $4.94B | $5.04B | $4.99B | $5.15B | $5.15B | $5.14B | $5.23B | $5.17B | $5.17B | $5.36B | $5.01B | $5.14B | $5.19B | $5.17B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $417.80M | $248.80M | $438.84M | $428.30M | $163.54M |
| Depreciation and Amortization | $304.65M | $319.68M | $332.41M | $342.01M | $329.92M |
| Deferred Income Tax | $- | $- | $- | $-10.69M | $229.35M |
| Stock Based Compensation | $36.70M | $35.07M | $27.30M | $21.41M | $18.82M |
| Change in Working Capital | $32.85M | $-15.10M | $-45.58M | $-94.03M | $-30.84M |
| Accounts Receivables | $- | $- | $-58.01M | $-75.38M | $-23.26M |
| Inventory | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $- | $- | $- | $- |
| Other Working Capital | $32.85M | $-15.10M | $12.43M | $-18.65M | $-7.58M |
| Other Non Cash Items | $-42.57M | $29.29M | $-127.24M | $35.12M | $-2.55M |
| Net Cash Provided by Operating Activities | $749.43M | $617.74M | $625.73M | $722.14M | $708.26M |
| Investments in Property Plant and Equipment | $- | $- | $-47.22M | $-95.06M | $-75.11M |
| Acquisitions Net | $-971.00K | $-12.35M | $-113.00K | $-16.21M | $-10.03M |
| Purchases of Investments | $- | $- | $-619.22M | $-164.79M | $-167.94M |
| Sales Maturities of Investments | $95.05M | $11.38M | $759.05M | $111.11M | $149.87M |
| Other Investing Activities | $-765.24M | $202.00K | $350.36M | $-359.21M | $14.15M |
| Net Cash Used for Investing Activities | $-671.16M | $-770.00K | $442.85M | $-524.17M | $-89.06M |
| Debt Repayment | $-487.48M | $-227.92M | $8.11M | $96.82M | $14.05M |
| Common Stock Issued | $1.24B | $336.40M | $8.11M | $274.01M | $151.86M |
| Common Stock Repurchased | $- | $- | $-142.27M | $- | $- |
| Dividends Paid | $-685.45M | $-643.87M | $-632.89M | $-637.65M | $-612.31M |
| Other Financing Activities | $-36.41M | $62.07M | $-30.51M | $-74.30M | $-39.15M |
| Net Cash Used Provided by Financing Activities | $26.32M | $-473.31M | $-789.45M | $-341.12M | $-485.55M |
| Effect of Forex Changes on Cash | $-580.00K | $430.00K | $-2.90M | $7.00K | $527.00K |
| Net Change in Cash | $104.00M | $144.09M | $276.23M | $-143.15M | $134.18M |
| Cash at End of Period | $548.74M | $444.73M | $300.64M | $24.41M | $167.56M |
| Cash at Beginning of Period | $444.73M | $300.64M | $24.41M | $167.56M | $33.38M |
| Operating Cash Flow | $749.43M | $617.74M | $625.73M | $722.14M | $708.26M |
| Capital Expenditure | $- | $- | $-47.22M | $-95.06M | $-75.11M |
| Free Cash Flow | $749.43M | $617.74M | $578.51M | $627.07M | $633.14M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $116.47M | $111.76M | $113.86M | $67.36M | $56.52M | $93.91M | $61.52M | $36.84M | $46.71M | $105.06M | $91.92M | $195.16M | $34.24M | $142.84M | $86.86M | $164.37M | $63.07M | $-93.77M | $101.96M | $92.28M |
| Depreciation and Amortization | $78.61M | $77.25M | $74.23M | $74.56M | $75.67M | $80.80M | $82.02M | $81.19M | $83.74M | $82.71M | $83.21M | $82.75M | $85.27M | $86.10M | $85.80M | $84.85M | $82.62M | $81.07M | $83.59M | $82.64M |
| Deferred Income Tax | $- | $- | $- | $- | $21.63M | $176.23M | $19.97M | $- | $- | $- | $- | $- | $64.07M | $-25.99M | $22.84M | $-71.61M | $24.71M | $207.32M | $-3.03M | $354.00K |
| Stock Based Compensation | $9.20M | $9.08M | $9.19M | $9.23M | $8.76M | $8.76M | $8.81M | $8.74M | $6.79M | $6.81M | $6.85M | $6.86M | $4.50M | $5.71M | $5.81M | $5.40M | $4.44M | $5.12M | $4.62M | $4.63M |
| Change in Working Capital | $30.13M | $1.66M | $10.39M | $-9.32M | $9.14M | $1.04M | $6.11M | $-31.38M | $16.70M | $-14.44M | $-1.23M | $-46.62M | $-34.88M | $-24.51M | $-1.64M | $-33.00M | $24.00M | $-17.10M | $4.28M | $-42.02M |
| Accounts Receivables | $3.04M | $23.00K | $491.00K | $915.00K | $-2.38M | $-673.00K | $-790.00K | $180.00K | $-4.76M | $-14.12M | $-13.08M | $-26.05M | $-30.72M | $-18.41M | $-11.76M | $-14.48M | $-12.51M | $-10.80M | $5.14M | $-5.09M |
| Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $27.09M | $1.63M | $9.90M | $-10.24M | $11.51M | $1.71M | $6.89M | $-31.55M | $21.46M | $-317.00K | $11.85M | $-20.57M | $-4.16M | $-6.10M | $10.12M | $-18.52M | $36.51M | $-6.30M | $-861.00K | $-36.93M |
| Other Non Cash Items | $-5.44M | $-13.28M | $133.90M | $168.02M | $-6.75M | $-189.71M | $-8.05M | $15.95M | $-245.00K | $-13.29M | $-7.75M | $-105.95M | $3.33M | $3.14M | $2.67M | $25.97M | $-1.49M | $-1.19M | $-1.04M | $1.18M |
| Net Cash Provided by Operating Activities | $228.97M | $186.47M | $184.41M | $152.42M | $164.98M | $171.02M | $170.38M | $111.36M | $153.68M | $166.85M | $172.99M | $132.20M | $156.53M | $187.28M | $202.35M | $175.97M | $197.36M | $181.45M | $190.38M | $139.07M |
| Investments in Property Plant and Equipment | $- | $-8.27M | $-7.07M | $-6.94M | $-14.71M | $-10.11M | $2.70K | $-5.34M | $7.98M | $-11.46M | $-3.31M | $-4.67M | $-3.14M | $-72.63M | $-9.49M | $-9.81M | $-13.12M | $-15.24M | $-19.02M | $-27.73M |
| Acquisitions Net | $- | $-484.00K | $545.00K | $-61.00K | $-172.00K | $-3.98M | $-228.00K | $22.00K | $113.00K | $5.00K | $-113.00K | $22.00K | $-8.23M | $85.22M | $-41.00K | $-7.94M | $-7.85M | $-204.00K | $-1.48M | $-495.00K |
| Purchases of Investments | $- | $- | $-287.69M | $-75.94M | $-244.84M | $-134.56M | $-298.13M | $-62.40M | $305.22M | $-106.62M | $-98.38M | $-100.22M | $-70.57M | $-45.67M | $-20.92M | $-27.64M | $-51.47M | $-48.77M | $-43.88M | $-23.81M |
| Sales Maturities of Investments | $- | $- | $85.90M | $24.43M | $352.97M | $213.05M | $114.63M | $17.56M | $607.86M | $50.65M | $44.35M | $56.19M | $19.48M | $35.10M | $4.62M | $51.91M | $50.63M | $50.99M | $35.16M | $13.08M |
| Other Investing Activities | $-281.73M | $-124.71M | $30.00K | $10.06M | $18.07M | $8.18M | $-3.60M | $52.82M | $-750.74M | $62.68M | $157.28M | $226.04M | $-9.56M | $-67.03M | $35.02M | $-402.86M | $-11.26M | $53.99M | $-12.38M | $-16.20M |
| Net Cash Used for Investing Activities | $-281.73M | $-133.46M | $-208.28M | $-48.40M | $111.32M | $72.58M | $-187.33M | $2.66M | $170.43M | $-4.75M | $99.83M | $177.34M | $-72.02M | $-65.01M | $9.19M | $-396.33M | $-33.09M | $40.77M | $-41.59M | $-55.15M |
| Debt Repayment | $-2.51M | $-78.35M | $-371.64M | $-41.88M | $-227.74M | $5.82M | $-4.09M | $-1.91M | $-1.90M | $-30.69M | $-312.99M | $353.31M | $-1.88M | $-1.87M | $-136.85M | $237.42M | $-14.08M | $-64.62M | $-301.86M | $394.62M |
| Common Stock Issued | $434.43M | $526.04M | $242.84M | $32.35M | $8.66M | $126.13M | $199.63M | $1.99M | $2.29M | $2.33M | $2.34M | $1.15M | $1.58M | $47.71M | $151.60M | $73.13M | $151.00M | $-410.00K | $-34.00K | $1.83M |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-114.95M | $-27.32M | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $-181.45M | $-173.28M | $-165.96M | $-164.76M | $-164.57M | $-164.49M | $-157.44M | $-157.38M | $-157.34M | $-157.29M | $-157.63M | $-160.64M | $-160.58M | $-160.55M | $-158.22M | $-158.30M | $-152.57M | $-152.58M | $-152.56M | $-154.60M |
| Other Financing Activities | $-7.07M | $-6.28M | $-4.98M | $-11.73M | $-6.14M | $-9.31M | $86.64M | $-9.12M | $-5.03M | $-2.74M | $-14.77M | $-5.26M | $-5.18M | $-5.98M | $-19.36M | $29.44M | $-22.36M | $-5.84M | $-4.78M | $-6.69M |
| Net Cash Used Provided by Financing Activities | $243.41M | $268.13M | $-299.75M | $-186.02M | $-389.79M | $-41.84M | $124.97M | $-166.44M | $-161.97M | $-190.72M | $-597.99M | $161.24M | $-166.14M | $-120.69M | $-162.84M | $108.56M | $-38.02M | $-223.45M | $-459.24M | $235.16M |
| Effect of Forex Changes on Cash | $- | $1.62M | $-280.00K | $297.00K | $298.00K | $-353.00K | $206.00K | $279.00K | $325.00K | $-1.67M | $-1.15M | $-407.00K | $36.00K | $-133.00K | $-32.00K | $136.00K | $1.19M | $-221.00K | $-12.00K | $-429.00K |
| Net Change in Cash | $188.43M | $321.18M | $-323.89M | $-81.70M | $-113.19M | $201.41M | $107.99M | $-52.13M | $162.47M | $-30.29M | $-326.32M | $470.37M | $-81.59M | $1.45M | $48.66M | $-111.66M | $127.44M | $-1.45M | $-310.46M | $318.64M |
| Cash at End of Period | $548.74M | $360.31M | $39.13M | $363.03M | $444.73M | $557.92M | $356.51M | $248.52M | $300.64M | $138.18M | $168.46M | $494.78M | $24.41M | $106.00M | $104.56M | $55.90M | $167.56M | $40.12M | $41.56M | $352.02M |
| Cash at Beginning of Period | $360.31M | $39.13M | $363.03M | $444.73M | $557.92M | $356.51M | $248.52M | $300.64M | $138.18M | $168.46M | $494.78M | $24.41M | $106.00M | $104.56M | $55.90M | $167.56M | $40.12M | $41.56M | $352.02M | $33.38M |
| Operating Cash Flow | $228.97M | $186.47M | $184.41M | $152.42M | $164.98M | $171.02M | $170.38M | $111.36M | $153.68M | $166.85M | $172.99M | $132.20M | $156.53M | $187.28M | $202.35M | $175.97M | $197.36M | $181.45M | $190.38M | $139.07M |
| Capital Expenditure | $- | $-8.27M | $-7.07M | $-6.94M | $-14.71M | $-10.11M | $2.70K | $-5.34M | $7.98M | $-11.46M | $-3.31M | $-4.67M | $-3.14M | $-72.63M | $-9.49M | $-9.81M | $-13.12M | $-15.24M | $-19.02M | $-27.73M |
| Free Cash Flow | $228.97M | $178.20M | $177.34M | $145.47M | $150.27M | $160.91M | $170.38M | $106.02M | $161.66M | $155.39M | $169.68M | $127.53M | $153.39M | $114.65M | $192.86M | $166.17M | $184.24M | $166.21M | $171.36M | $111.33M |
Omega Healthcare Investors Dividends
Explore Omega Healthcare Investors's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
7.02%
Dividend Payout Ratio
168.69%
Dividend Paid & Capex Coverage Ratio
1.09x
Omega Healthcare Investors Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.67 | $0.67 | February 10, 2025 | February 10, 2025 | February 18, 2025 | January 29, 2025 |
| $0.67 | $0.67 | November 04, 2024 | November 04, 2024 | November 15, 2024 | October 25, 2024 |
| $0.67 | $0.67 | August 05, 2024 | August 05, 2024 | August 15, 2024 | July 24, 2024 |
| $0.67 | $0.67 | April 29, 2024 | April 30, 2024 | May 15, 2024 | April 18, 2024 |
| $0.67 | $0.67 | February 02, 2024 | February 05, 2024 | February 15, 2024 | January 26, 2024 |
| $0.67 | $0.67 | October 30, 2023 | October 31, 2023 | November 15, 2023 | October 20, 2023 |
| $0.67 | $0.67 | July 28, 2023 | July 31, 2023 | August 15, 2023 | July 20, 2023 |
| $0.67 | $0.67 | April 28, 2023 | May 01, 2023 | May 15, 2023 | April 20, 2023 |
| $0.67 | $0.67 | February 03, 2023 | February 06, 2023 | February 15, 2023 | January 26, 2023 |
| $0.67 | $0.67 | October 31, 2022 | November 01, 2022 | November 15, 2022 | October 21, 2022 |
| $0.67 | $0.67 | July 29, 2022 | August 01, 2022 | August 15, 2022 | July 21, 2022 |
| $0.67 | $0.67 | April 29, 2022 | May 02, 2022 | May 13, 2022 | April 21, 2022 |
| $0.67 | $0.67 | February 04, 2022 | February 07, 2022 | February 15, 2022 | January 27, 2022 |
| $0.67 | $0.67 | November 04, 2021 | November 05, 2021 | November 15, 2021 | October 26, 2021 |
| $0.67 | $0.67 | July 30, 2021 | August 02, 2021 | August 13, 2021 | July 22, 2021 |
| $0.67 | $0.67 | April 30, 2021 | May 03, 2021 | May 17, 2021 | April 22, 2021 |
| $0.67 | $0.67 | February 05, 2021 | February 08, 2021 | February 16, 2021 | January 28, 2021 |
| $0.67 | $0.67 | October 30, 2020 | November 02, 2020 | November 16, 2020 | October 22, 2020 |
| $0.67 | $0.67 | July 30, 2020 | July 31, 2020 | August 14, 2020 | July 15, 2020 |
| $0.67 | $0.67 | April 29, 2020 | April 30, 2020 | May 15, 2020 | April 13, 2020 |
Omega Healthcare Investors News
Read the latest news about Omega Healthcare Investors, including recent articles, headlines, and updates.
DRH or OHI: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of DiamondRock Hospitality (DRH) and Omega Healthcare Investors (OHI). But which of these two companies is the best option for those looking for undervalued stocks?
Omega Healthcare: The Pullback Is An Opportunity As The Risk-Free Rate Of Return Declines
Omega Healthcare Investors rebounded in 2024, surpassing $1 billion in annual revenue and investing $1.1 billion in new properties and loans. Despite a recent 15% decline, OHI's valuation remains attractive, with strong revenue, EBITDA growth, and a high dividend yield of 7.29%. Risks include dependency on Medicare/Medicaid policies, interest rate hikes, and $4.44 billion in long-term debt, potentially impacting profitability and dividend coverage.
Bargain Alert: I'm Buying These 7-11% Yields For Recurring Income
Market volatility underscores the need for income-producing assets; Crescent Capital BDC and Omega Healthcare Investors offer compelling value with strong fundamentals and attractive yields. Crescent Capital BDC carries a diversified portfolio, high-quality secured debt, robust liquidity, and an 11% dividend yield while trading at a 15% discount to NAV. Omega Healthcare Investors benefits from a stable triple-net lease model, improving operator fundamentals, and a 7.3% dividend yield, with potential for capital appreciation.
Omega Healthcare Investors: Surge In Short Interest Calls For Caution
The recent surge in short interest for Omega Healthcare Investors stock reflects large earnings uncertainties ahead in my view. The top uncertainties on my list include potential FFO headwinds if the higher-for-longer scenario persists for inflation and rates. Valuation risks are also elevated when the P/FFO ratio is adjusted for growth.
All 15 Maplewood Senior Living Communities and Inspῑr Carnegie Hill Receive Reputation.com's Esteemed Awards
Leading Platform in Reputation Experience Management Awards 2025 Winners for Going Above and Beyond on Delivering Brand Promises WESTPORT, Conn. , March 5, 2025 /PRNewswire/ -- Maplewood Senior Living, known for its upscale senior living residences, is proud to announce that all of its communities, fifteen on the East Coast and in the Midwest, and their flagship Inspῑr location, Inspῑr Carnegie Hill, located on the Upper East side of Manhattan, NY, have been awarded the 2025 top honors from Reputation.com, the leading platform in reputation experience management.
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have little impact on skilled nursing facility REITs, and the current selloff presents a buying opportunity for CareTrust REIT. Single-family rental REITs face challenges from high home prices and mortgage rates, but offer quality rental homes and professional management.
Top 4 Healthcare REITs Turning Care Into Big Investor Payouts
Healthcare is an industry that's constantly in demand, making it an investor favorite when choosing corporate shares to hold in the long term. Past data has found that healthcare stocks also tend to weather inflation better than others, beating inflation about 50% of the time during volatile periods.
Buried Treasures: 4 Dramatically Undervalued REITs
REITs are highly attractive now due to stable or falling interest rates and low inflation, with many offering strong yields while being undervalued. This article identifies 27 REITs yielding at least 75 basis points above the no-risk rate on Treasuries, while selling at discounts of 20% or greater to their Target Fair Value. The list is then screened for dividend safety, to eliminate sucker yields, and for stable revenues, excluding those with flat or declining FFO/share.
Buy These 7-11% Yielding Cash Cows For Retirement Income
Capital Southwest offers an 11% yield, strong balance sheet, and robust deal flow, making it a compelling investment in the underserved lower middle market. Omega Healthcare Investors provides a 7.4% yield, steady long-term leases, and improving operator fundamentals, offering growth in supply constrained markets. Both CSWC and OHI present attractive high-yielding opportunities, offering stability and potentially strong returns amidst market volatility and high-growth stock pressures.
Surprise, Surprise: Two More REIT Buys
This is a good time to invest in REITs due to stable or falling interest rates and low inflation, with Citigroup predicting 10-15% returns in 2025. Healthcare REITs are being boosted by both increased income (Cost of Living Adjustments) for their senior housing and skilled nursing patients, and a 15-year low in new construction starts. Industrials are enjoying a rotation after a 15% selloff despite stellar operating performance in 2024. Meanwhile, absorption (demand) is finally catching up to completions (supply), following a 2-year glut.
Inspīr Embassy Row Celebrates Grand Opening, Ushering in New Era of Luxury Senior Living in Washington D.C.
WASHINGTON , Feb. 13, 2025 /PRNewswire/ -- Maplewood Senior Living and Omega Healthcare Investors, Inc. (NYSE: OHI) celebrates the grand opening of Inspīr Embassy Row, Washington D.C.'s premier ultra-luxury senior living community, located in the historic Fairfax at Embassy Row building.
Omega Healthcare Investors, Inc. (OHI) Q4 2024 Earnings Conference Call Transcript
Omega Healthcare Investors, Inc. (NYSE:OHI ) Q4 2024 Earnings Conference Call February 6, 2025 10:00 AM ET Company Participants Michele Reber - IR Taylor Pickett - CEO Bob Stephenson - CFO Megan Krull - SVP, Operations Matthew Gourmand - President Vikas Gupta - Chief Investment Office Conference Call Participants Jonathan Hughes - Raymond James Michael Griffin - Citi John Kilichowski - Wells Fargo Juan Sanabria - BMO Capital Markets Nick Yulico - Scotia Bank Farrell Granath - Bank of America Merrill Lynch Michael Carroll - RBC Capital Markets Alec Feygin - Baird Emily Meckler - Green Street Vikram Malhotra - Mizuho Operator Thank you for standing by. My name is Kate and I will be your conference operator today.
Compared to Estimates, Omega Healthcare Investors (OHI) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omega Reports Fourth Quarter and Full Year 2024 Results
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter and year ended December 31, 2024. FOURTH QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $116 million, or $0.41 per common share, compared to $57 million, or $0.22 per common share, for Q4 2023. Nareit Funds From Operations (“Nareit FFO”) for the quarter of $196 million, or $0.68 per common share, on 287 million weighted-average.
Omega Announces Quarterly Dividend
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Tuesday, February 18, 2025, to common stockholders of record as of the close of business on Monday, February 10, 2025. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its po.
Omega Healthcare Investors: Improving Dividend Health
Omega Healthcare Investors is a leading healthcare REIT focused on skilled nursing facilities, benefiting from aging U.S. population trends and improved pay-out metrics. Despite Covid-related setbacks, OHI has maintained a $0.67 per share quarterly dividend, offering a well-covered 7% yield and moderate valuation. OHI's adjusted funds from operations have grown, allowing potential portfolio expansion and a favorable risk/reward relationship at a $36 price point.
Omega Announces Fourth Quarter Earnings Release Date and Conference Call
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2024, on Wednesday, February 5, 2025, after market close. In conjunction with its release, Omega will be conducting a conference call on Thursday, February 6, 2025, at 10 a.m. Eastern Time to review its 2024 fourth quarter results and current developments. To listen to the conference call via webcast, log on to www.
Omega Healthcare Investors: Covered Dividend And Transformation Make It A Buy
Omega Healthcare Investors is a leading triple-net lease REIT specializing in skilled nursing facilities, offering a 7.2% yield supported by improving fundamentals. OHI has shown resilience, evidenced by strong Q3 results, revenue growth, and a fully covered dividend, making it an attractive buy. Strategic investments in senior housing and operator recoveries position OHI to capitalize on growing demand from an aging population.
Omega Announces Key Leadership Changes
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) (the “Company” or “Omega”) today announced key leadership changes. Matthew Gourmand, previously Senior Vice President, Corporate Strategy & Investor Relations, has been appointed President, and Vikas Gupta, previously Senior Vice President, Acquisitions & Development, has been appointed Chief Investment Officer. Separately, after 23 years as Chief Operating Officer, Dan Booth has stepped down from his positio.
CHCT or OHI: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Community Healthcare Trust (CHCT) and Omega Healthcare Investors (OHI). But which of these two companies is the best option for those looking for undervalued stocks?
Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
CIO vs. OHI: Which Stock Should Value Investors Buy Now?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both City Office REIT (CIO) and Omega Healthcare Investors (OHI). But which of these two stocks presents investors with the better value opportunity right now?
At-The-Market Issuance By U.S. REITs Hits All-Time Quarterly High In Q3 2024
Total proceeds raised by US equity real estate investment trusts through at-the-market offering programs rocketed to an all-time high in the third quarter. US REITs raised an aggregate of $7.21 billion in proceeds through their at-the-market programs during the quarter. By property sector, healthcare REITs raised the most capital through their ATM programs during the quarter, at $2.65 billion.
Omega Healthcare: Back To Pre-Pandemic Levels, But I Think It Consolidates (Rating Downgrade)
OHI produced a strong Q3 beating on the top and bottom line as they came in ahead of the consensus estimate of $0.38 EPS with $0.42. OHI continued to make progress in Q3 having completed $440 million in new investments which included real estate acquisitions. I am downgrading my outlook to neutral as shares have run more than 30% in 2024 and look fairly valued compared to OHI's peers.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for OHI.